Turtle Beach jumps after raising Q2 revenue outlook Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Turtle Beach (HEAR) up 29% after raising its Q2 revenue view to $74M-$77M from $42M-$47M based on continued strong demand and significant additional increases in product supply
- Ideaya (IDYA) and GlaxoSmithKline (GSK) up 67% and 2%, respectively, after the companies announced a strategic partnership in Synthetic Lethality
for Oncology
- McDonald's (MCD) up 1% after reporting same store sales figures for April and May
- IQIY (IQ) up 38% after Reuters reported Tencent (TCEHY) is looking to become the biggest shareholder in
the company
- Annovis Bio (ANVS) up 34% after completing the rat cohort of a chronic toxicology study of its lead therapeutic compound ANVS401, reporting no negative side effects
- Sanofi (SNY) up 1% after its investigational enzyme replacement therapy, avalglucosidase alfa
met the primary endpoint demonstrating non-inferiority in improving respiratory function compared to the standard of care in patients with LOPD
- Eli Lilly (LLY) up 9% after its Verzenio breast cancer study met its primary endpoint
LOWER -
- NeoPhotonics (NPTN) down 2% after B. Riley FBR analyst Davig Kang downgraded the stock to Neutral from Buy with a $10 price target
- Izea (IZEA) down 4% after Ladenburg analyst Jon Hickman downgraded shares to Neutral from Buy with an unchanged price target of $2
- Acuity Brands (AYI) down 1% after Goldman Sachs analyst Brian Lee downgraded the stock to Sell from Neutral with an $80 price target.
Symbols:
LLY HEAR IDYA GSK MCD IQ ANVS SNY NPTN IZEA AYI Keywords: Fly Intel, Wall Street, Top Stories, Stocks